Two teams at the CHUM Research Centre have received grants from the John R. Evans Leaders Fund of the Canada Foundation for Innovation (CFI) and from the Ministère de l’Économie, de la Science et de l’Innovation du Québec to fund new research infrastructure.
The grants received by An Tang on the one hand, and Adriana Di Polo and Nicole Leclerc on the other, will allow these researchers to procure new research equipment. The CFI and the Government of Quebec are funding 80% of the projects, with 20% coming from various other partners.
An Tang – $750,000 in funding
Development and clinical transfer of imaging biomarkers for diffuse and focal liver disease
An Tang, a CHUM radiologist and researcher and a professor at the Université de Montréal, will work on developing and validating ultrasound and magnetic resonance imaging (MRI) to measure the amount of fibrosis, inflammation or excess fat or iron in the liver. The infrastructure to be acquired will contribute to the development and evaluation of noninvasive diagnostic strategies for diffuse and focal liver disease. This work will make it possible to diagnose chronic hepatopathies representing risk factors for liver cancer.
Adriana Di Polo and Nicole Leclerc – $250,000 in funding
A retinal imaging platform for the discovery of ocular biomarkers for age-related neurodegenerative diseases
Adriana Di Polo and Nicole Leclerc, CHUM researchers and professors at the Université de Montréal, will develop new retinal biomarkers for early diagnosis of glaucoma and Alzheimer’s disease. The eye offers a unique opportunity for in vivo imaging. Because of the transparency of the cornea, the lens and intraocular fluids, it is possible to directly and noninvasively visualize the retina. With the state-of-the-art imaging equipment procured, the researchers want to use the retina as a window to detect early pathological changes in neurodegenerative diseases in order to develop new, noninvasive diagnostic tools and test different therapeutic approaches.
To find out more:
Source: University of Montreal Hospital Research Centre (CRCHUM)